Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the features of high-risk myelodysplastic syndrome
- Relate the first-line treatment options for high-risk myelodysplastic syndrome
- Describe the factors to consider in allogeneic stem cell transplantation in myelodysplastic syndrome
- Explain the use of hypomethylating agents in high-risk myelodysplastic syndrome
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.